<DOC>
	<DOC>NCT01138514</DOC>
	<brief_summary>The purpose of this study is to compare the efficacy and safety profiles of Perrigo Israel Pharmaceuticals, Ltd. Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel and BenzaclinÂ® Topical Gel (Clindamycin- Benzoyl Peroxide Gel).</brief_summary>
	<brief_title>Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>Healthy men or women, 12 to 65 years of age Willing to participate and sign provide written consent Moderate to severe acne Pregnant or lactating women History of unresponsiveness or hypersensitivity to clindamycin, benzoyl peroxide or lincomycin Use of systemic, topical or facial products which may interfere with the study Participation in any clinical study in the 30 days prior to study entry Prolonged exposure to sunlight or excessive exposure to UV lights Chronic use of NSAIDS</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>